327 related articles for article (PubMed ID: 34679240)
1. Agrypnia excitata as the main feature in anti-leucine-rich glioma-inactivated 1 encephalitis: a detailed clinical and polysomnographic semiological analysis.
Piffer S; Cantalupo G; Filipponi S; Poretto V; Pellegrini M; Tanel R; Buganza M; Giometto B
Eur J Neurol; 2022 Mar; 29(3):890-894. PubMed ID: 34679240
[TBL] [Abstract][Full Text] [Related]
2. Clinical features of 28 cases of anti
Feng J; Li J; Xie Y; Lü Y; Bi F; Zhou J
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Mar; 48(3):386-396. PubMed ID: 37164922
[TBL] [Abstract][Full Text] [Related]
3. A case of pediatric anti-leucine-rich glioma inactivated 1 encephalitis with faciobrachial dystonic seizure.
Jang S; Kim SY; Kim WJ; Chae JH; Kim KJ; Lim BC
Brain Dev; 2023 Jun; 45(6):348-353. PubMed ID: 36858863
[TBL] [Abstract][Full Text] [Related]
4. Autoimmune encephalitis associated with voltage-gated potassium channels-complex and leucine-rich glioma-inactivated 1 antibodies - a national cohort study.
Celicanin M; Blaabjerg M; Maersk-Moller C; Beniczky S; Marner L; Thomsen C; Bach FW; Kondziella D; Andersen H; Somnier F; Illes Z; Pinborg LH
Eur J Neurol; 2017 Aug; 24(8):999-1005. PubMed ID: 28544133
[TBL] [Abstract][Full Text] [Related]
5. Anti-leucine-rich Glioma Inactivated-1 Encephalitis Associated with Essential Thrombocythemia.
Yuan X; Man X; Zhang J; Sun J; Liang J; Ma H; Tao S; Guo D; Liu L
Intern Med; 2020; 59(2):271-275. PubMed ID: 31941873
[TBL] [Abstract][Full Text] [Related]
6. Antibody-LGI 1 autoimmune encephalitis manifesting as rapidly progressive dementia and hyponatremia: a case report and literature review.
Li X; Yuan J; Liu L; Hu W
BMC Neurol; 2019 Feb; 19(1):19. PubMed ID: 30732585
[TBL] [Abstract][Full Text] [Related]
7. What Is Different about Teratoma-Associated Anti-LGI1 Encephalitis? A Long-Term Clinical and Neuroimaging Case Series.
Li C; Cai HB; Zhao X; Xi XC; Zhou Q; Luo HY; Tang ZP; Kang HC; Kirsch HE
Eur Neurol; 2022; 85(6):437-445. PubMed ID: 35896086
[TBL] [Abstract][Full Text] [Related]
8. Neurological, psychiatric, and sleep investigations after treatment of anti-leucine-rich glioma-inactivated protein 1 (LGI1) encephalitis in Spain: a prospective cohort study.
Muñoz-Lopetegi A; Guasp M; Prades L; Martínez-Hernández E; Rosa-Justícia M; Patricio V; Armangué T; Rami L; Borràs R; Castro-Fornieles J; Compte A; Gaig C; Santamaria J; Dalmau J;
Lancet Neurol; 2024 Mar; 23(3):256-266. PubMed ID: 38365378
[TBL] [Abstract][Full Text] [Related]
9. Persistent hiccup as one of the initial symptoms of leucine-rich glioma-inactivated-1 encephalitis: a case report.
Hou L; Wan L; Li H; Wang Z; Guan H; Ren H; Wang P
BMC Neurol; 2022 Jul; 22(1):281. PubMed ID: 35896991
[TBL] [Abstract][Full Text] [Related]
10. Confusion and Hallucination in a Geriatric Patient. Pitfalls of a Rare Differential: Case Report of an Anti-LGI1-Encephalitis.
Meier L; Weinrebe W; Annoni JM; Petersen JA
Clin Interv Aging; 2022; 17():1423-1432. PubMed ID: 36187571
[TBL] [Abstract][Full Text] [Related]
11. Bi-Basal Ganglia Involvement with Signal Evolution in a Case of Anti-LGI1 Encephalitis.
Gai Q; Ruan S; Dong X; Cong S
Neurol India; 2022; 70(1):384-386. PubMed ID: 35263922
[TBL] [Abstract][Full Text] [Related]
12. [Clinical analysis of 9 cases with Anti-leucine-rich glioma inactivated 1 protein antibody associated limbic encephalitis].
Zhang YX; Yang HL; Wu YY; Wang CC; Gao XY; Shi YY; Liu HQ; Huang Y; Zhang JW
Zhonghua Yi Xue Za Zhi; 2017 May; 97(17):1295-1298. PubMed ID: 28482428
[No Abstract] [Full Text] [Related]
13. A rare case of anti-LGI1 limbic encephalitis with concomitant positive NMDAR antibodies.
Ji T; Huang Z; Lian Y; Wang C; Zhang Q; Li J
BMC Neurol; 2020 Sep; 20(1):336. PubMed ID: 32894089
[TBL] [Abstract][Full Text] [Related]
14. Case Report: Anti-LGI1 Limbic Encephalitis Associated With Anti-thyroid Autoantibodies.
Otiniano-Sifuentes R; Cuba Antezana A; De La Cruz Ramirez WF; Pacheco-Barrios K; Segura Chavez DA
Front Neurol; 2020; 11():620483. PubMed ID: 33519701
[TBL] [Abstract][Full Text] [Related]
15. Clinical Features, Immunotherapy, and Outcomes of Anti-Leucine-Rich Glioma-Inactivated-1 Encephalitis.
Huang X; Fan C; Gao L; Li L; Ye J; Shen H
J Neuropsychiatry Clin Neurosci; 2022; 34(2):141-148. PubMed ID: 34794327
[TBL] [Abstract][Full Text] [Related]
16. Case Report/Case Series: Rare case of anti-LGI1 limbic encephalitis with rapidly progressive dementia, psychiatric symptoms, and frequently seizures: A case report.
Wu H; Mei F; Liu L; Zhang L; Hao H; Zhang S
Medicine (Baltimore); 2021 Jul; 100(29):e26654. PubMed ID: 34398024
[TBL] [Abstract][Full Text] [Related]
17. Faciobrachial dystonic seizures: the influence of immunotherapy on seizure control and prevention of cognitive impairment in a broadening phenotype.
Irani SR; Stagg CJ; Schott JM; Rosenthal CR; Schneider SA; Pettingill P; Pettingill R; Waters P; Thomas A; Voets NL; Cardoso MJ; Cash DM; Manning EN; Lang B; Smith SJ; Vincent A; Johnson MR
Brain; 2013 Oct; 136(Pt 10):3151-62. PubMed ID: 24014519
[TBL] [Abstract][Full Text] [Related]
18. [Ictal electroencephalography (EEG) activity and cerebral blood flow dynamics as potential pathological indicators: a case of anti-leucine-rich glioma-inactivated 1 protein (LGI1) encephalitis].
Ishibashi H; Neshige S; Aoki S; Ueno H; Iida K; Maruyama H
Rinsho Shinkeigaku; 2020 Nov; 60(11):778-785. PubMed ID: 33115994
[TBL] [Abstract][Full Text] [Related]
19. Case Report: Paroxysmal hyperhidrosis as an initial symptom in a patient with anti-LGI1 encephalitis.
Qiao T; Chen L; Jiang L; Wei H; Chen X; Li X; Chen Y; Xu Y
Front Immunol; 2022; 13():986853. PubMed ID: 36211373
[TBL] [Abstract][Full Text] [Related]
20. Agrypnia excitata.
Provini F
Curr Neurol Neurosci Rep; 2013 Apr; 13(4):341. PubMed ID: 23423537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
